the HLA-DQ 3-chain is highly associated with disease susceptibility,3 whereas in rheumatoid arthritis, basic amino acids at positions 70 and 71 shared among certain HLA-DR4 subgroups and HLA-DR1 confer disease susceptibility.4 HLA genotyping, either by direct sequencing of these individual genes or by the use of multiple-sequence specific oligonucleotide probes,5 has provided the technology that has aided such discrete correlations of disease susceptibility with nucleic acid sequences.
Indirect evidence suggests that pulmonary hypertension (PHT) may be associated with autoimmune disease in some patients. For example, Raynaud's phenomenon is known to be associated with primary pulmonary hypertension (PPH)647; positive antinuclear antibodies (ANA) occur frequently in PPH8; and an increased incidence of anti-Ku autoantibodies has been demonstrated in PPH. 9 Also, PHT is a clinical component in many autoimmune disorders, for example, systemic lupus erythematosus (SLE),101' scleroderma,"2 rheumatoid arthritis,'3 poly/dermatomyositis,14 and mixed connective tissue disease.'5 Despite these suggestive findings, only two recent abstracts, using serologically determined HLA alleles, have reported alterations in their frequencies in PHT when compared with those found in normals. Gladman et al16 found an increase in DRw52 in scleroderma with PHT, and Barst et al17 found an increase in DR3 or DRw6 in children with unexplained PHT. In the present study, ANAs, specific autoantibodies, and serologically determined HLA-A, B, C, DR, and DQ typing were performed on two groups of children with unexplained PHT and their parents. Seventeen children had PPH and 13 children had PHT and anatomically large congenital pulmonary to systemic communications but with the development of pulmonary vascular disease occurring earlier than is normally seen, that is, not consistent with natural history studies of uncomplicated ventricular septal defects (VSDs), patent ductus arteriosus (PDA), or atrial septal defects (ASDs). 18 We studied this latter group in an attempt to further our understanding of why some children with anatomically large shunt lesions have a predisposition to the development of early pulmonary vascular obstructive disease. Because there is evidence for an autoimmune component in some patients with PPH, we questioned whether there also is evidence for autoimmune phenomena contributing to an abnormal reactivity of the pulmonary vascular bed in these children with congenital heart defects as well. Our working hypothesis was that there may be an autoimmune component in one or both of these two groups of children with unexplained PHT.
Methods
Informed consent by parents was obtained for each patient. The study was approved by the institutional review board of Columbia University College of Physicians and Surgeons. PHT was documented by cardiac catheterization in 30 Caucasian children consecutively referred to the Children's Pulmonary Hypertension Center, Columbia-Presbyterian Medical Center (CPMC), for unexplained PHT. HLA associations vary in ethnically different populations, therefore, this initial study was confined to Caucasians. The children, 20 girls and 10 boys, ranged in age from 6 months to 16 years.
Patient Groups
The children were divided into two groups (Table  1) . Group 1 consisted of 17 children with PPH including two patients with familial PPH (FPPH) and three patients with PHT associated with trivial congenital pulmonary to systemic communications. Two children had a tiny patent ductus arteriosus (PDA) and one child had a small VSD. The latter three children were considered to have congenital heart defects anatomically too small to account for their PHT. Group 2 consisted of 13 children with anatomically large congenital pulmonary to systemic communications but with unexplained early pulmonary vascular disease (PHT+shunt). The unexplained pulmonary vascular disease is defined as pulmonary vascular disease occurring earlier than normally seen in children with anatomically large shunt lesions18 or developing in children followed closely from early infancy without previously demonstrating hyperkinetic highflow PHT. The clinical course of the children in group 2 was not consistent with natural history studies of uncomplicated VSDs, PDAs, or ASDs. Three children underwent surgical repair during infancy with preoperative cardiac catheterizations demonstrating high pulmonary blood flow, high pulmonary pressure, and low pulmonary vascular resistance. All three children were in congestive heart failure preoperatively. One infant underwent PDA ligation at 3 months of age, one infant underwent PDA ligation and closure of a secundum ASD at 6 months of age, and one child underwent closure of a large subaortic VSD at 1.4 years of age with a cardiac catheterization 1 week before repair demonstrating a large left-to-right shunt with low pulmonary vascular resistance. Despite surgical intervention, these three children developed progressive pulmonary vascular obstructive disease postoperatively. The remaining 10 children never had clinical evidence of increased pulmonary blood flow. These children were never in congestive heart failure clinically and did not have significant failure to thrive. Four children had an anatomically large PDA and two patients had a large subaortic VSD. Two children presented with persistent fetal circulation early in life without involution of fetal pulmonary arterial architecture resulting in persistent severe PHT. One child had a common atrium diagnosed at 3.9 years without a history of congestive heart failure or failure to thrive; he presented with signs and symptoms of PHT. The last child in group 2 was a 6.6-year-old girl who had been followed closely for portal hypertension and was diagnosed as having severe PHT after a syncopal None of the 29 fathers tested were ANA+. The frequencies of control +ANAs used those published for normal children, less than 6%,22 and those for normal adults, less than 6%. 23 Autoantibodies. Three children and one mother in the PPH group had low titers of anti-Ku. Two children, one in each group with Down's syndrome, developed low titers of anti-DNA antibodies over time. Autoantibody titers in the mothers also include high titers of rheumatoid factor in group 2 patient 5's mother and antitopoisomerase 1 in group 1 patient 13's mother.26 Anti-Ku, an autoantibody to a DNAbinding nuclear protein complex originally described in sera from patients with polymyositis-scleroderma overlap syndrome, has now been associated with many similar diseases such as SLE, scleroderma, myositis, and Sjogren's syndrome, in addition to PPH.27 Anti-DNA antibodies occur in many of these diseases but are most highly associated with SLE. Antitopoisomerase 1 is specific for diffuse visceral scleroderma. Anti-Sm, anti-RNP, anti-Ro, anti-La, anticentromere, anti-Jol, and anticardiolipin antibodies were not found in the PHT children or their mothers. Specific autoantibodies have not yet been The small sample size also precluded ANA-autoantibody/HLA correlations. However, anti-Ku previously associated with HLA-DQw127 was found in three PPH children and one PPH mother.
The PPH children had statistically significant increases in DR3, DRw52, and DQw2 (p=0.014, 0.043, and 0.016, respectively) but with decreased DR5 (p =0.045). An increase in DRw8 in the PPH children almost reached statistical significance (p= 0.052). In contrast, group 2 PHT children showed no alterations in any of the DR or DQ alleles, and the slight increase in DRw6 failed to achieve statistical significance (p=0.117).
There were no class I (HLA-A, B, C) associations readily apparent in any of the PHT groups (data not illustrated). The Al, B8, DR3, DRw52, DQw2 haplotype was present in 80% of DR3+ children. The Tables 4 and 5 , respectively. Summaries of the statistically significant differences in the distribution of HLA-DR and DQ for the children and their parents are provided in Table 6 . PPH mothers had significantly decreased DQw3 (p=0.039). In contrast, group 2 mothers, like their children, did not show any significant associations with any DR or DQ allele. Although not statistically significant, decreased DR4 was found in association with the decrease in DQw3. HLA-DR4, -DR5, and -DR9 are found in linkage disequilibrium with DQw3. The PPH and group 2 fathers did not show any significant association with any of the DR or DQ alleles.
Comparison of HLA in PHT Children and Their Parents
Because the statistically significant associations with the class II alleles for the children, mothers, and fathers were derived by comparisons with those found in normal controls, the next series of statistical evaluations sought to determine whether the children inherited the parental biases in a skewed fashion. The two study groups were statistically too small to evaluate whether there was a parental bias in the inheritance of each allele. Interestingly, both familial PPH children had DR3. Patient 10 (DR3, DRw6) had maternally derived DR3 and PPH, and patient 1 had DR3 via both parents and paternally derived PPH. Discussion PPH is a well described but poorly understood illness. PPH has been associated with autoimmune phenomena previously,8'9 although the association remains unclear. In addition to studying children with PPH (group 1), we also looked at children with PHT associated with anatomically large congenital pulmonary to systemic communications but with unexplained early pulmonary vascular disease (group 2). The clinical course of these children was not consistent with natural history studies.'8 We wondered if an autoimmune basis triggered, contributed to, or exacerbated the rapid development of pulmonary vascular obstructive disease in these children. We found positive ANAs, autoantibodies, and familial aggregation of autoimmune diseases in children and mothers of both groups. Despite these similarities, there was an HLA class II association for the children with PPH but not for the group 2 children with PHT+shunt. The discussion that follows examines sequentially the ramifications of the immunogenetics, autoantibodies, and familial clustering of autoimmune diseases found in each group.
The most important immunogenetic findings in this study were the increases in HLA class II alleles DR3, DRw52, and DQw2 and decreased DR5 in children with PPH (group 1). There were no alterations in any of the HLA-DR or DQ frequencies in the group 2 children. These data suggest that PPH may be positively associated with DR3, DRw52, and DQw2 and negatively associated with DR5. Future studies of age-and sex-matched children with similar congenital heart defects without unexplained early pulmonary vascular disease will be required to determine whether these children also lack an association with these HLA alleles. No association of childhood PHT with any of the HLA class I alleles was found. The data in this small series would not be statistically significant if adjusted for the number of alleles studied. Nevertheless, childhood PPH is a rare disease, and HLA typing has not previously been reported in either adult or juvenile PPH. In this light, the genetic trends are of interest. The HLA study of the parents showed that only group 1 PPH mothers had an alteration of a DR or DQ allele, which was negatively associated with DQw3. The maternal negative DQw3 bias was not found in either PHT patient group. These results raise an interesting possibility that there may be preferential transmission of class II alleles within the HLA gene complex.32,33 In a nonautoimmune study, DR3 was shown to be paternally derived in 83% of the offspring.32 In diabetes, DR4+ fathers were more likely to preferentially transmit their HLA-DR4-linked, diabetes-predisposing allele to both their diabetic and nondiabetic children than were the DR4+ mothers. 33 The alterations in inheritance of HLA alleles could not be studied because of the small size of both study groups. The transmission in the two DR3+ children with familial PPH showed one HLA-DR3, DRw6 child had DR3 and PPH from her mother and the other had DR3 from both parents and PPH from her father.
Increased susceptibility to autoimmune diseases such as diabetes and rheumatoid arthritis3-5 has been more intimately associated with specific amino acids in the peptide-binding area of the various polymorphic HLA class II molecules. Because of linkage disequilibrium, it is impossible to predict which alleles or epitopes in the DR3, DRw52, DQw2 haplotype are important for disease susceptibility for PPH. It is interesting to speculate that the HLA heterogeneity found in the two PHT groups could be united by an epitope shared among the different alleles that correlates with susceptibility to PHT. Examination of the published nucleotide sequences for the known DR Bi, B3, and B4 genes provides a potentially associated epitope at amino acid positions [67] [68] [69] [70] [71] in the third hypervariable region of the first domain of these genes, which could be shared by 100% of the PHT children. 34 The amino acid sequences 67LLEQR71, also LLEQK or LLERR, are found in DRw52a, b, c, DR3, DRw14 (subtype of DRw6), and DR4 subtypes excluding DwlO Clustering of autoimmune diseases and/or autoantibodies in certain kindreds is also a common finding in autoimmunity. This clustering was found in four families and included two from each group with ANA+ mothers. Three mothers (scleroderma with antitopoisomerase 1, rheumatoid arthritis with rheumatoid factor, and hypothyroidism, arthritis, and Raynaud's phenomenon with an uncharacterized autoantibody) and one sibling (linear scleroderma) had autoimmune diseases. It is not known whether these kindreds represent unique examples or whether all of the kindreds will develop autoimmune diseases over time. All of the PHT children developed the disease beyond the neonatal period, which suggests that transplacental transfer of an autoantibody was not a direct pathogenetic factor as it is in neonatal SLE, where the transplacental transfer of anti-Ro and/or anti-La causes congenital heart block. 48 Mechanistically, the precise etiology of autoimmune diseases is thought to involve some combination of environmental, hormonal, and genetic factors. We purposely sought PHT children for these immunogenetic studies because they have experienced fewer environmental, hormonal, and aging effects, all of which influence the immune system in multifactorial ways. The HLA molecules, through their properties of antigen binding,1 selection of T cell receptors in the thymus,2 and interaction with T cell receptors in the periphery, provide a sequence of immunological interactions that could be studied to ascertain whether they are the same or different for children with PPH versus PHT+shunt. Lacking these data, the finding of an HLA class II association for childhood PPH suggests that it is an autoimmune disease.
Although HLA susceptibility genes are permissive for disease, subject to additional genetic and environmental modifying influences, this information is presently of little predictive value in the individual patient with PPH. Less clear is whether the group of children with PHT associated with congenital shunts, who lacked an HLA class II association, have an immunological basis, possibly autoimmune, for the development of early unexplained pulmonary vascular obstructive disease. Recently, elevated lymph levels of the cytokine transforming growth factor 18 (TGF-p8), which is one of several smooth muscle mitogens, have been found in an experimental model of PHT in sheep. 49 The authors felt that TGF-,8 might contribute to the development of the structural changes in the pulmonary arteries that occur during the onset of chronic pulmonary hypertension. Whether this or another similar mitogen is elicited via a stimulus involving an immunogenetic predisposition requires further investigation for both PPH and congenital heart disease with and without PHT. Autoimmune diseases often respond to anti-inflammatory and/or immunosuppressive therapy; therefore, the answers to these questions may have therapeutic implications.
